Schedule 13G ownership disclosure

Entrada Therapeutics Inc

Common Stock · CUSIP: 29384C108

Event date: 2025-06-30

Filing-level shares
1,521,281
Percent of class
4.0%
  • JANUS HENDERSON GROUP PLC

    Shares: 1,521,281 · Class: 4.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000202
Form type
SCHEDULE 13G/A
Filer
Entrada Therapeutics, Inc.
CIK
CIK 1689375
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub